Grifols, S.A. Net Income 2012-2024 | GRFS

Grifols, S.A. annual/quarterly net income history and growth rate from 2012 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Grifols, S.A. net income for the quarter ending September 30, 2024 was $0.057B, a 40.88% decline year-over-year.
  • Grifols, S.A. net income for the twelve months ending September 30, 2024 was $0.013B, a 97.99% decline year-over-year.
  • Grifols, S.A. annual net income for 2023 was $0.064B, a 70.75% decline from 2022.
  • Grifols, S.A. annual net income for 2022 was $0.219B, a 1.72% decline from 2021.
  • Grifols, S.A. annual net income for 2021 was $0.223B, a 68.4% decline from 2020.
Grifols, S.A. Annual Net Income
(Millions of US $)
2023 $64
2022 $219
2021 $223
2020 $707
2019 $700
2018 $705
2017 $749
2016 $604
2015 $591
2014 $621
2013 $454
2012 $328
2011 $70
Grifols, S.A. Quarterly Net Income
(Millions of US $)
2024-09-30 $57
2024-06-30 $16
2023-06-30 $57
2023-03-31 $-116
2022-06-30 $96
2021-06-30 $165
2019-06-30 $194
2018-06-30 $209
2017-06-30 $158
2017-03-31 $143
2016-12-31 $150
2016-09-30 $158
2016-06-30 $157
2016-03-31 $138
2015-12-31 $144
2015-09-30 $156
2015-06-30 $147
2015-03-31 $145
2014-12-31 $149
2014-09-30 $151
2014-06-30 $139
2014-03-31 $168
2013-12-31 $104
2013-09-30 $112
2013-06-30 $121
2013-03-31 $118
2012-12-31 $76
2012-09-30 $80
2012-06-30 $85
2012-03-31 $87
2011-12-31 $9
2011-09-30 $35
Sector Industry Market Cap Revenue
Medical MED-DRUGS $5.122B $7.134B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) JP $83.888B 33.10
Zoetis Inc. (ZTS) US $71.853B 27.10
Takeda Pharmaceutical Co. (TAK) JP $44.737B 9.90
Daiichi Sankyo Co., Ltd. - Sponsored ADR (DSNKY) JP $43.224B 26.34
Sandoz Group AG Sponsored ADR (SDZNY) CH $20.442B 0.00
Merck KGaA (MKKGY) DE $18.230B 16.33
Astellas Pharma Inc. (ALPMY) JP $17.608B 12.47
Summit Therapeutics PLC (SMMT) US $16.312B 0.00
United Therapeutics Corporation (UTHR) US $16.121B 15.86
Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) JP $12.709B 0.00
Neurocrine Biosciences, Inc. (NBIX) US $12.033B 36.68
Orion OYJ Unsponsored ADR (ORINY) FI $7.681B 21.59
Madrigal Pharmaceuticals, Inc. (MDGL) US $7.333B 0.00
Corcept Therapeutics Incorporated (CORT) US $6.657B 50.43
Stevanato Group S.p.A. (STVN) IT $6.329B 40.98
Hikma Pharmaceuticals Plc (HKMPF) GB $6.245B 0.00
Ionis Pharmaceuticals, Inc. (IONS) US $5.138B 0.00
Ono Pharmaceutical Co. (OPHLF) JP $4.650B 9.52
Recursion Pharmaceuticals, Inc. (RXRX) US $3.626B 0.00
Crinetics Pharmaceuticals, Inc. (CRNX) US $3.474B 0.00
Catalyst Pharmaceuticals, Inc. (CPRX) US $2.579B 11.69
AMNEAL PHARMACEUTICALS, INC. (AMRX) US $2.426B 14.50
Centessa Pharmaceuticals PLC Sponsored ADR (CNTA) GB $2.193B 0.00
Hypermarcas (HYPMY) BR $2.154B 0.00
Soleno Therapeutics, Inc. (SLNO) US $1.989B 0.00
BioCryst Pharmaceuticals, Inc. (BCRX) US $1.908B 0.00
NewAmsterdam Pharma Company N.V. (NAMS) NL $1.716B 0.00
Evotec AG (EVO) DE $1.573B 0.00
Dyne Therapeutics, Inc. (DYN) US $1.426B 0.00
Guardian Pharmacy Services, Inc. (GRDN) US $1.239B 0.00
Ardelyx, Inc. (ARDX) US $1.198B 0.00
Indivior PLC (INDV) US $1.165B 5.06
Aurinia Pharmaceuticals Inc (AUPH) CA $1.135B 0.00
Xencor, Inc. (XNCR) US $1.102B 0.00
Ocular Therapeutix, Inc. (OCUL) US $1.101B 0.00
ARS Pharmaceuticals, Inc. (SPRY) US $1.092B 0.00
Enliven Therapeutics, Inc. (ELVN) US $1.065B 0.00
Harrow, Inc. (HROW) US $1.031B 0.00
Collegium Pharmaceutical, Inc. (COLL) US $0.939B 5.13
Bioventus Inc. (BVS) US $0.812B 25.67
Avadel Pharmaceuticals PLC. (AVDL) IE $0.810B 0.00
Cronos Group Inc. (CRON) CA $0.754B 0.00
Relay Therapeutics, Inc. (RLAY) US $0.656B 0.00
Verve Therapeutics, Inc. (VERV) US $0.616B 0.00
USANA Health Sciences, Inc. (USNA) US $0.606B 11.23
Xeris Biopharma Holdings, Inc. (XERS) US $0.559B 0.00
Elite Pharmaceuticals Inc. (ELTP) US $0.521B 0.00
OmniAb, Inc. (OABI) US $0.515B 0.00
KalVista Pharmaceuticals, Inc. (KALV) US $0.496B 0.00
Savara Inc. (SVRA) US $0.462B 0.00
Theravance Biopharma, Inc. (TBPH) KY $0.458B 0.00
Altimmune, Inc. (ALT) US $0.457B 0.00
ProKidney Corp. (PROK) US $0.437B 0.00
Siga Technologies Inc. (SIGA) US $0.422B 4.92
Zevra Therapeutics, Inc. (ZVRA) US $0.410B 0.00
Organogenesis (ORGO) US $0.404B 0.00
Aldeyra Therapeutics, Inc. (ALDX) US $0.398B 0.00
Akebia Therapeutics, Inc. (AKBA) US $0.393B 0.00
Oruka Therapeutics, Inc. (ORKA) US $0.386B 0.00
CytoDyn Inc. (CYDY) US $0.368B 0.00
Esperion Therapeutics, Inc. (ESPR) US $0.359B 0.00
Rigel Pharmaceuticals, Inc. (RIGL) US $0.354B 143.50
Tourmaline Bio, Inc. (TRML) US $0.313B 0.00
Ironwood Pharmaceuticals, Inc. (IRWD) US $0.290B 0.00
Aquestive Therapeutics, Inc. (AQST) US $0.274B 0.00
Heron Therapeutics, Inc. (HRTX) US $0.263B 0.00
Avita Medical Inc. (RCEL) US $0.256B 0.00
Nature's Sunshine Products, Inc. (NATR) US $0.252B 14.98
Korro Bio, Inc. (KRRO) US $0.246B 0.00
Innate Pharma SA (IPHYF) FR $0.243B 0.00
Amylyx Pharmaceuticals, Inc. (AMLX) US $0.226B 0.00
Profound Medical (PROF) CA $0.225B 0.00
4D Molecular Therapeutics, Inc. (FDMT) US $0.215B 0.00
Inhibikase Therapeutics, Inc. (IKT) US $0.206B 0.00
Lyell Immunopharma, Inc. (LYEL) US $0.205B 0.00
Larimar Therapeutics, Inc. (LRMR) US $0.204B 0.00
MediWound Ltd. (MDWD) IL $0.191B 0.00
Nanobiotix S.A. Sponsored ADR (NBTX) FR $0.177B 0.00
Acrivon Therapeutics, Inc. (ACRV) US $0.172B 0.00
Nektar Therapeutics (NKTR) US $0.172B 0.00
Enanta Pharmaceuticals, Inc. (ENTA) US $0.171B 0.00
VAXART, INC. (VXRT) US $0.162B 0.00
Aclaris Therapeutics, Inc. (ACRS) US $0.160B 0.00
Silence Therapeutics PLC Sponsored ADR (SLN) GB $0.143B 0.00
Champions Oncology, Inc. (CSBR) US $0.141B 0.00
Inotiv, Inc. (NOTV) US $0.137B 0.00
Lexeo Therapeutics, Inc. (LXEO) US $0.129B 0.00
Procaps Group, S.A. (PROCF) LU $0.126B 0.00
Cassava Sciences, Inc. (SAVA) US $0.123B 0.00
electroCore, Inc. (ECOR) US $0.118B 0.00
Telomir Pharmaceuticals, Inc. (TELO) US $0.116B 0.00
Achieve Life Sciences, Inc. (ACHV) CA $0.109B 0.00
Journey Medical Corporation (DERM) US $0.108B 0.00
Corbus Pharmaceuticals Holdings, Inc. (CRBP) US $0.100B 0.00
Cardiol Therapeutics Inc. (CRDL) CA $0.099B 0.00
Galectin Therapeutics Inc. (GALT) US $0.094B 0.00
Arch Biopartners Inc. (ACHFF) CA $0.089B 0.00
Metagenomi, Inc. (MGX) US $0.088B 0.00
Avalo Therapeutics, Inc. (AVTX) US $0.088B 0.00
Regulus Therapeutics Inc. (RGLS) US $0.086B 0.00
Nutriband Inc. (NTRB) US $0.083B 0.00
Assertio Holdings, Inc. (ASRT) US $0.078B 20.32
Protara Therapeutics, Inc. (TARA) US $0.077B 0.00
ESSA Pharma Inc. (EPIX) CA $0.076B 0.00
Pyxis Oncology, Inc. (PYXS) US $0.076B 0.00
Karyopharm Therapeutics Inc. (KPTI) US $0.076B 0.00
Cumberland Pharmaceuticals Inc. (CPIX) US $0.075B 0.00
PMV Pharmaceuticals, Inc. (PMVP) US $0.073B 0.00
FibroGen, Inc (FGEN) US $0.071B 0.00
Mural Oncology PLC (MURA) IE $0.069B 0.00
Fractyl Health, Inc. (GUTS) US $0.068B 0.00
Vivani Medical, Inc. (VANI) US $0.068B 0.00
Unicycive Therapeutics, Inc. (UNCY) US $0.064B 0.00
Century Therapeutics, Inc. (IPSC) US $0.062B 0.00
AleAnna Inc. (ANNA) US $0.062B 0.00
Context Therapeutics Inc. (CNTX) US $0.061B 0.00
Gain Therapeutics, Inc. (GANX) US $0.060B 0.00
OptiNose, Inc. (OPTN) US $0.058B 0.00
Reviva Pharmaceuticals Holdings, Inc. (RVPH) US $0.053B 0.00
Dominari Holdings Inc. (DOMH) US $0.052B 0.00
Iterum Therapeutics PLC (ITRM) IE $0.052B 0.00
Rafael Holdings, Inc. (RFL) US $0.050B 0.00
AlloVir, Inc. (ALVR) US $0.049B 0.00
Prelude Therapeutics Incorporated (PRLD) US $0.048B 0.00
SCYNEXIS, Inc. (SCYX) US $0.041B 0.00
VYNE Therapeutics Inc. (VYNE) US $0.040B 0.00
NRx Pharmaceuticals, Inc. (NRXP) US $0.039B 0.00
CASI Pharmaceuticals Inc. (CASI) CN $0.038B 0.00
Tempest Therapeutics, Inc. (TPST) US $0.038B 0.00
Surrozen, Inc. (SRZN) US $0.036B 0.00
Verrica Pharmaceuticals Inc. (VRCA) US $0.034B 0.00
PolyPid Ltd. (PYPD) IL $0.030B 0.00
Incannex Healthcare Inc. (IXHL) AU $0.029B 0.00
Jupiter Neurosciences, Inc. (JUNS) US $0.028B 0.00
BioVie Inc. (BIVI) US $0.027B 0.00
Natural Alternatives International, Inc. (NAII) US $0.025B 0.00
DURECT Corporation (DRRX) US $0.025B 0.00
Scienture Holdings, Inc. (SCNX) US $0.024B 0.00
Enlivex Therapeutics Ltd. (ENLV) IL $0.021B 0.00
Mannatech, Incorporated (MTEX) US $0.021B 0.00
GlycoMimetics, Inc. (GLYC) US $0.019B 0.00
Carisma Therapeutics Inc. (CARM) US $0.019B 0.00
Vivos Therapeutics, Inc. (VVOS) US $0.018B 0.00
Lipocine Inc. (LPCN) US $0.018B 0.00
MEI Pharma, Inc. (MEIP) US $0.017B 0.00
Tonix Pharmaceuticals Holding Corp. (TNXP) US $0.017B 0.00
MARKER THERAPEUTICS, INC. (MRKR) US $0.017B 0.00
Traws Pharma, Inc. (TRAW) US $0.016B 0.00
Citius Pharmaceuticals, Inc. (CTXR) US $0.015B 0.00
Biomerica, Inc. (BMRA) US $0.015B 0.00
TherapeuticsMD, Inc. (TXMD) US $0.015B 0.00
Cosmos Health Inc. (COSM) US $0.014B 0.00
Lyra Therapeutics, Inc. (LYRA) US $0.013B 0.00
ProPhase Labs, Inc. (PRPH) US $0.013B 0.00
Minerva Neurosciences, Inc (NERV) US $0.013B 0.00
Nuvilex Inc. (PMCB) US $0.012B 0.00
BioLineRx Ltd. (BLRX) IL $0.012B 0.00
Phio Pharmaceuticals Corp. (PHIO) US $0.012B 0.00
Indaptus Therapeutics, Inc. (INDP) US $0.011B 0.00
Mangoceuticals, Inc. (MGRX) US $0.011B 0.00
Kiora Pharmaceuticals, Inc. (KPRX) US $0.010B 0.00
Klotho Neurosciences, Inc. (KLTO) US $0.010B 0.00
Talphera, Inc. (TLPH) US $0.010B 0.00
Jaguar Animal Health, Inc. (JAGX) US $0.010B 0.00
Relmada Therapeutics, Inc. (RLMD) US $0.009B 0.00
Ainos, Inc. (AIMD) US $0.009B 0.00
Addex Therapeutics Ltd. Sponsored ADR (ADXN) CH $0.008B 0.00
XTL Biopharmaceuticals Ltd. (XTLB) IL $0.008B 0.00
Plus Therapeutics, Inc. (PSTV) US $0.007B 0.00
NLS Pharmaceutics Ltd. (NLSP) CH $0.007B 0.00
Xenetic Biosciences, Inc. (XBIO) US $0.006B 0.00
Redhill Biopharma Ltd. (RDHL) IL $0.006B 0.00
Aptorum Group Limited (APM) GB $0.006B 0.00
TransCode Therapeutics Inc. (RNAZ) US $0.006B 0.00
Clearmind Medicine Inc. (CMND) CA $0.006B 0.00
CERo Therapeutics Holdings, Inc. (CERO) US $0.005B 0.00
SciSparc Ltd. (SPRC) IL $0.005B 0.00
Conduit Pharmaceuticals Inc. (CDT) US $0.004B 0.00
Sonoma Pharmaceuticals, Inc. (SNOA) US $0.004B 0.00
InMed Pharmaceuticals Inc. (INM) CA $0.004B 0.00
60 Degrees Pharmaceuticals Inc. (SXTP) US $0.003B 0.00
XORTX Therapeutics Inc. (XRTX) CA $0.003B 0.00
Avenue Therapeutics, Inc. (ATXI) US $0.003B 0.07
Alaunos Therapeutics, Inc. (TCRT) US $0.003B 0.00
Qualigen Therapeutics, Inc. (QLGN) US $0.003B 0.00
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) US $0.003B 0.00
SHINECO (SISI) CN $0.002B 0.00
Salarius Pharmaceuticals, Inc. (SLRX) US $0.002B 0.00
Galmed Pharmaceuticals Ltd. (GLMD) IL $0.002B 0.00
Heatwurx Inc. (PCSA) US $0.002B 0.00
Quoin Pharmaceuticals, Ltd. Sponsored ADR (QNRX) US $0.002B 0.00
Petros Pharmaceuticals, Inc. (PTPI) US $0.001B 0.00
China SXT Pharmaceuticals, Inc. (SXTC) CN $0.001B 0.00
TNF Pharmaceuticals, Inc. (TNFA) US $0.001B 0.00
Aditxt Inc. (ADTX) US $0.001B 0.00
PainReform Ltd. (PRFX) IL $0.000B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.000B 0.00
4D pharma PLC Sponsored ADR (LBPS) GB $0.000B 0.00
Patheon N.V. (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals PLC (RVLP) US $0.000B 0.00